Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

193.07 +1.66 (+0.86%)
Streaming Delayed Price Updated: 1:27 PM EDT, Apr 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Q4 Earnings Roundup: Quest (NYSE:DGX) And The Rest Of The Testing & Diagnostics Services Segment
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
News headline image
3 Cash-Producing Stocks That Fall Short
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
3 Mid-Cap Stocks with Warning Signs
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
3 Reasons to Avoid DGX and 1 Stock to Buy Instead
Since September 2025, Quest has been in a holding pattern, posting a small return of 4.5% while floating around $195.43. However, the stock is beating the S&... 
Via StockStory
Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Sustainable Dividend Stock ↗
Via Chartmill
Quest Diagnostics Inc (NYSE:DGX) Beats Q4 Estimates, Announces Dividend Hike and $1B Buyback ↗
Via Chartmill
Quest Diagnostics Inc (NYSE:DGX) Offers a Reliable Dividend with Strong Growth and Profitability ↗
Via Chartmill
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
The Great Migration: Outpatient Care Stocks Surge as Aging Populations and AI Reshape American Healthcare
As of March 17, 2026, the American healthcare landscape is undergoing its most significant structural transformation in decades. The traditional hospital-centric model is rapidly giving way to a... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
5 Insightful Analyst Questions From Quest’s Q4 Earnings Call
Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic... 
Via StockStory
Topics Artificial Intelligence Earnings
Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends ↗
Via Chartmill
News headline image
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
On February 11, 2026, the clinical laboratory landscape is recalibrating following a whirlwind 48 hours of financial and regulatory news. Quest Diagnostics (NYSE: DGX), the nation’s leading provider of... 
Via Finterra
Topics Artificial Intelligence
News headline image
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Quest (DGX) Stock Soaring Today
Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.8% in the afternoon session after the company reported strong fourth-quarter financial results and offered an upbeat... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike ↗
Quest Diagnostics (NYSE: DGX) reported Q4 earnings of $2.42 per share, beating expectations. Sales were $2.81B, up 7.1% YoY. 
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Quest Diagnostics (DGX) Earnings Call Transcript ↗
Quest Diagnostics (DGX) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q4 CY2025, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue... 
Via StockStory
News headline image
Quest (DGX) Q4 Earnings: What To Expect
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be announcing earnings results this Tuesday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Should You Buy Guardant Health Before Feb. 19? ↗
This genomics stock appears to be at an inflection point. 
Via The Motley Fool
Topics Earnings
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
3 Mid-Cap Stocks We Find Risky
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Quest trades at $179.96 and has moved in lockstep with the market. Its shares have returned 6.9% over the last six months while the S&P 500 has gained 11.3%. 
Via StockStory
Topics Stocks
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an... 
Via MarketMinute
News headline image
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting... 
Via StockStory
News headline image
Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Dependable Dividend Stock ↗
Quest Diagnostics (DGX) offers a reliable dividend with a strong yield, backed by consistent growth, solid profitability, and a sustainable payout ratio for income investors. 
Via Chartmill
News headline image
1 S&P 500 Stock to Target This Week and 2 We Brush Off
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Quest (DGX) Q3 2025 Earnings Call Transcript ↗
Quest (DGX) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.